How a Ketogenic Diet Affects Hormones and Metabolism in Women (SHEKAN)
Strategic Hormonal Evaluation in Keto-Adaptation
This study is looking at how a ketogenic diet (a way of eating that is high in fat and very low in carbohydrates) affects hormones, metabolism, and body composition in healthy women who have regular menstrual cycles. While ketogenic diets have become popular and have been studied in men and in people with certain health conditions, much less is known about how this way of eating affects the hormones and cycles of healthy, premenopausal women.
Researchers believe that a ketogenic diet may cause measurable changes in reproductive hormones (such as estrogen and progesterone), metabolic markers (like ketone and cholesterol levels), and body composition (such as body fat and lean muscle mass) across the menstrual cycle. The study will also explore whether the diet affects mood, sleep, and overall well-being.
Participants will follow a ketogenic diet for 12 weeks, roughly covering three menstrual cycles. During the first month, they will receive help with meal planning and food, and for the remaining weeks they will follow the diet on their own with continued support from a dietitian. Throughout the study, participants will check in weekly for blood draws, body composition scans, and a resting metabolism test, and will use at-home tools such as a smart ring and daily finger-stick tests to track their ketone levels and hormone patterns. Participants will also complete surveys about their mood, sleep, and general well-being.
By studying these changes closely, the research team hopes to better understand how a ketogenic diet affects women's health and hormones, which could help guide future dietary recommendations designed specifically for women.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
etogenic diets induce a metabolic shift from glucose to fat as the primary energy substrate, resulting in nutritional ketosis and associated changes in insulin sensitivity, lipid profiles, and body composition. While ketogenic diets have been studied extensively in the context of epilepsy, obesity, type 2 diabetes, and neurodegenerative disease, most existing research either underrepresents women or fails to account for hormonal fluctuations across the menstrual cycle. Preliminary evidence suggests that sex hormones and substrate metabolism differ meaningfully between men and women in their response to dietary interventions, yet these differences remain poorly characterized during ketogenic adaptation, particularly in healthy, regularly menstruating women.
This pilot study is designed to characterize the physiological, hormonal, metabolic, and behavioral adaptations that occur during a 12-week, well-formulated ketogenic diet in healthy, premenopausal women, capturing data across approximately three consecutive menstrual cycles. The diet is structured in two phases: an initial 4-week period with controlled feeding support (grocery provision or meal delivery services matched to individual caloric needs), followed by 8 weeks of self-guided dietary adherence supported by ongoing dietitian consultation and educational materials. Dietary adherence and ketosis status (target: ≥0.5 mmol/L blood BHB) are monitored daily via at-home fingerstick testing.
Participants attend weekly in-person study visits for the duration of the 12-week intervention, during which fasting venous blood is drawn to assess reproductive hormone levels, resting metabolic rate is measured via indirect calorimetry, and body composition is tracked using bioelectrical impedance (InBody). Full-body DXA scans, which provide a more precise measure of fat mass, lean mass, and visceral adiposity, are performed only at baseline and at the final Week 16 visit, in order to limit participants' cumulative radiation exposure. Menstrual cycle phase and ovulatory status are tracked continuously using a wearable basal body temperature ring and urine-based hormone test strips, allowing the research team to align hormonal blood draws with specific points in each participant's cycle. Validated PROMIS instruments are used to assess mood, sleep quality, anxiety, depression, and cognitive function at scheduled intervals throughout the study.
As a pilot study, SHEKAN is designed primarily to assess feasibility and estimate effect sizes to inform the design of future, larger-scale investigations, rather than to test a specific hypothesis with adequate statistical power to detect small between-group differences. Findings are intended to help characterize sex-specific responses to ketogenic diets and inform future research and clinical guidance regarding women's metabolic and reproductive health during dietary intervention.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
Ohio
-
Columbus、Ohio、アメリカ、43210
- 募集
- Physical Activity and Educational Services Building
-
コンタクト:
- Program Manager Department of Human Sciences - Kinesiology
- 電話番号:6142470287
- メール:roe.236@osu.edu
-
主任研究者:
- Madison Kackley, PhD, Kinesiology
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Healthy Women aged 18-40
- Self-reported, 27-32 day menstrual cycles
- Must have access to a smartphone, tablet or computer to access the diet survey and resources
- Must be willing to self-report menstrual cycles
Exclusion Criteria:
- History of reproductive disorders
- Pregnancy or lactation during the study period
- Recurring disordered eating behaviors or other food security concerns
- Suffered a lower body injury in the last 6 months
- Other major health concerns
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Ketogenic Diet Intervention Group
Healthy, premenopausal women (ages 18-40) with regular menstrual cycles will follow a 12-week well-formulated ketogenic diet designed to maintain nutritional ketosis (≥0.5 mmol/L BHB). During the first 4 weeks, participants receive controlled feeding support (grocery provision or meal delivery services). Weeks 5-12 transition to a self-guided ketogenic diet with continued dietitian support and educational resources. Participants undergo weekly in-person study visits (blood draws, resting metabolic rate testing, body composition scans, and validated surveys) plus daily at-home monitoring (fingerstick ketone/glucose testing, nightly wearable ring, and urine ovulation tracking) across approximately 16 weeks total, including baseline and final follow-up visits. |
A high-fat, low-carbohydrate, moderate-protein diet intended to induce and maintain nutritional ketosis over 12 weeks, with an initial 4-week period of controlled feeding support followed by 8 weeks of self-guided adherence with dietitian consultation and educational materials. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Ovulatory Status
時間枠:Baseline to 12 weeks
|
To evaluate whether ketogenic dietary intervention or exogenous ketone supplementation restores ovulatory function in women with Polycystic Ovary Syndrome (PCOS). Ovulatory status will be assessed using a combination of validated measures, including basal body temperature monitoring via BBT, urinary luteinizing hormone (LH) surge detection using ovulation predictor kits, and serum progesterone levels. Participants will be classified as ovulatory or anovulatory based on hormonal and temperature cycle confirmation. |
Baseline to 12 weeks
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Serum Progesterone Concentration (ng/mL)
時間枠:Baseline to 12 weeks
|
To determine the effects of ketogenic diet and exogenous ketone supplementation on circulating reproductive hormone concentrations. Serum progesterone will be analyzed using standard immunoassay techniques (Quest Diagnostics panels and/or validated ELISA assays). Hormonal changes will be compared between baseline and post-intervention to assess improvements in reproductive axis regulation. |
Baseline to 12 weeks
|
|
Change in Serum Estradiol Concentration (pg/mL)
時間枠:Baseline to 12 weeks
|
To determine the effects of ketogenic diet and exogenous ketone supplementation on circulating reproductive hormone concentrations. Serum estradiol will be analyzed using commercially available immunoassay kits (Quest Diagnostics panels and/or validated ELISA assays). Hormonal changes will be compared between baseline and post-intervention to assess improvements in reproductive axis regulation. |
Baseline to 12 weeks
|
|
Change in Serum Luteinizing Hormone Concentration (mIU/mL)
時間枠:Baseline to 12 weeks
|
To determine the effects of ketogenic diet and exogenous ketone supplementation on circulating reproductive hormone concentrations. Serum luteinizing hormone (LH) will be analyzed using standard immunoassay techniques (Quest Diagnostics panels and/or validated ELISA assays). Hormonal changes will be compared between baseline and post-intervention to assess improvements in reproductive axis regulation. |
Baseline to 12 weeks
|
|
Change in Serum Follicle Stimulating Hormone Concentrations (mIU/mL)
時間枠:Baseline to 12 weeks
|
To determine the effects of ketogenic diet and exogenous ketone supplementation on circulating reproductive hormone concentrations. Serum follicle-stimulating hormone (FSH) will be analyzed using standard immunoassay techniques (Quest Diagnostics panels and/or validated ELISA assays). Hormonal changes will be compared between baseline and post-intervention to assess improvements in reproductive axis regulation. |
Baseline to 12 weeks
|
|
Change in Daily Fasting BHB (mmol/L)
時間枠:Baseline to 12 weeks (Daily)
|
To assess changes in metabolic parameters including fasting β-hydroxybutyrate (BHB). Capillary ketones will be measured daily using KetoMojo handheld monitors. |
Baseline to 12 weeks (Daily)
|
|
Change in Daily Fasting Glucose (mg/dL)
時間枠:Baseline to 12 weeks (Daily)
|
To assess changes in metabolic parameters including fasting glucose. Capillary glucose will be measured daily using KetoMojo handheld monitors. |
Baseline to 12 weeks (Daily)
|
|
Change in Serum Insulin Concentration (µIU/mL)
時間枠:Baseline to 12 weeks
|
To assess the effect of ketogenic diet and exogenous ketone supplementation on fasting insulin levels. Serum insulin will be measured at laboratory visits via immunoassay (Quest Diagnostics or validated ELISA). Mean change from baseline will be compared across groups. |
Baseline to 12 weeks
|
|
Change in Serum Total Cholesterol Concentration (mg/dL)
時間枠:Baseline to 12 weeks
|
To assess changes in fasting serum total cholesterol in response to ketogenic diet and exogenous ketone supplementation. Blood samples will be collected biweekly and analyzed using standard clinical chemistry methods (Quest Diagnostics). Mean change from baseline to 12 weeks will be reported. |
Baseline to 12 weeks
|
|
Change in Serum Triglyceride Concentration (mg/dL)
時間枠:Baseline to 12 weeks
|
To determine the effect of ketogenic diet and exogenous ketone supplementation on fasting triglyceride concentrations. Serum triglycerides will be measured via standard lipid panel. Mean change from baseline to 12 weeks will be compared across groups. |
Baseline to 12 weeks
|
|
Change in Serum LDL Cholesterol Concentration (mg/dL)
時間枠:Baseline to 12 weeks
|
To assess the effect of ketogenic diet and exogenous ketone supplementation on fasting low-density lipoprotein (LDL) cholesterol. Serum LDL will be measured via standard lipid panel (Quest Diagnostics). Mean change from baseline to post-intervention will be reported. |
Baseline to 12 weeks
|
|
Change in Serum HDL Cholesterol Concentration (mg/dL)
時間枠:Baseline to 12 weeks
|
To evaluate changes in fasting high-density lipoprotein (HDL) cholesterol following ketogenic diet or exogenous ketone supplementation. Serum HDL will be analyzed by clinical chemistry methods. Mean change from baseline to 12 weeks will be reported. |
Baseline to 12 weeks
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Pereira HM, Larson RD, Bemben DA. Menstrual Cycle Effects on Exercise-Induced Fatigability. Front Physiol. 2020 Jun 26;11:517. doi: 10.3389/fphys.2020.00517. eCollection 2020.
- Sadoyama T, Masuda T, Miyano H. Relationships between muscle fibre conduction velocity and frequency parameters of surface EMG during sustained contraction. European Journal of Applied Physiology and Occupational Physiology. 1983;51(2):247-256. doi:10.1007/BF00455188
- De Luca CJ. The Use of Surface Electromyography in Biomechanics. Journal of Applied Biomechanics. 1997;13(2):135-163. doi:10.1123/jab.13.2.135.
- Bambaeichi E, Reilly T, Cable NT, Giacomoni M. The isolated and combined effects of menstrual cycle phase and time-of-day on muscle strength of eumenorrheic females. Chronobiol Int. 2004 Jul;21(4-5):645-60. doi: 10.1081/cbi-120039206.
- Thompson BM, Drover KB, Stellmaker RJ, Sculley DV, Janse de Jonge XAK. The Effect of the Menstrual Cycle and Oral Contraceptive Cycle on Muscle Performance and Perceptual Measures. Int J Environ Res Public Health. 2021 Oct 9;18(20):10565. doi: 10.3390/ijerph182010565.
- Tenan MS, Hackney AC, Griffin L. Maximal force and tremor changes across the menstrual cycle. Eur J Appl Physiol. 2016 Jan;116(1):153-60. doi: 10.1007/s00421-015-3258-x. Epub 2015 Sep 13.
- Bouchard TP, Fehring RJ, Mu Q. Quantitative versus qualitative estrogen and luteinizing hormone testing for personal fertility monitoring. Expert Rev Mol Diagn. 2021 Dec;21(12):1349-1360. doi: 10.1080/14737159.2021.2000393. Epub 2021 Dec 3.
- Papaioannou S, Aslam M, Al Wattar BH, Milnes RC, Knowles TG. User's acceptability of OvuSense: a novel vaginal temperature sensor for prediction of the fertile period. J Obstet Gynaecol. 2013 Oct;33(7):705-9. doi: 10.3109/01443615.2013.817984.
- Thiyagarajan DK, Basit H, Jeanmonod R. Physiology, Menstrual Cycle. 2024 Sep 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500020/
- Li D, Zhang L, Wang X. The Effect of Menstrual Cycle Phases on Approach-Avoidance Behaviors in Women: Evidence from Conscious and Unconscious Processes. Brain Sci. 2022 Oct 21;12(10):1417. doi: 10.3390/brainsci12101417.
- Corbie-Smith GM, Durant RW, St George DM. Investigators' assessment of NIH mandated inclusion of women and minorities in research. Contemp Clin Trials. 2006 Dec;27(6):571-9. doi: 10.1016/j.cct.2006.05.012. Epub 2006 Jul 13.
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- STUDY20250337
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Deidentified datasets (no direct identifiers; no genetic/genomic data, as none will be generated for this study)
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。